RLI Rallies Through Earnings, But Analysts Stay Cautious

RLI Corp. has delivered a sharp post-earnings move, and the question now is whether the analyst community, which mostly sat below the stock going into the print, will follow the price higher.

The stock closed at $62.71 on Tuesday, up 2.5% on the day and nearly 10% on the week. That puts it roughly 20% above the $52 levels where CEO Craig Kliethermes and COO Jennifer Klobnak were buying in late May. Those discretionary open-market purchases, none under a pre-arranged 10b5-1 plan, totalled around $1.1 million in aggregate. The cluster aged well: two directors added smaller positions in July, and the stock has not looked back. The earnings reaction on October 19 added 2.7% in a single session.

The analyst picture is more complicated than the price action suggests. Keefe, Bruyette and Woods moved constructively this week, with Meyer Shields raising his target to $74 while maintaining an Outperform rating. That is the most bullish target on the sheet and sits comfortably above the current price. Wells Fargo moved in the opposite direction. Hristian Getsov lifted his target to $53 from $51, but kept an Underweight rating, meaning the revised target is still 15% below where the stock is trading. Jefferies has an Underperform with a $53 target as well. The mean analyst target across the coverage group is $56.25, a level the stock has now decisively traded through. Two of the more active names on this ticker are technically bearish on a stock that has outrun their models. On valuation, the price-to-book multiple has moved to 3.34, up roughly 0.20 over the past week, reflecting the re-rating the market has applied post-print. The dividend score ranks in the 90th percentile, supported by a $2.00 special dividend declared in May. The EPS surprise factor ranks in the 88th percentile, consistent with a track record of beating estimates.

Options positioning has swung dramatically since Monday's pre-earnings extreme. The put/call ratio was at 0.20 heading into the Q3 release, more than four standard deviations below the 20-day average. It has since normalised toward 0.24, still well below the 20-day mean of 0.70 and nearly three standard deviations on the bullish side. Call demand has not fully evaporated post-earnings. Short interest sits at 9.6% of free float, up about 8% over the past month as shorts rebuilt positions into the stock's prior weakness. Borrow conditions remain undemanding: availability is at 273%, meaning there are more than two-and-a-half shares available to borrow for every share currently shorted, and the cost to borrow is just 0.52%. That is a loose lending market, and the short score of 69.6 has been broadly stable through the week. With 9.6% of float short and no squeeze pressure in the borrow, the overhang is real but manageable.

Wasatch Advisors added 405,000 shares in the quarter to September, making it one of the more active builders in the top-15 holder list. Invesco added around 595,000 shares over the same period. Both moves are notable for a mid-cap specialty insurer. The activist register is quiet, with all 13D/G filers holding passive stakes and no 13D on the register. Kayne Anderson Rudnick, the third-largest holder with a 7.4% stake as last disclosed, has not filed an update since February.

The next earnings date is January 21, 2027, giving the stock 92 days to resolve the tension between a price that has moved well beyond most analyst targets and a set of bears who have not yet abandoned their positions. Whether the Wells Fargo and Jefferies targets get revised up, or whether the shorts rebuild into the post-earnings strength, is the central question to track over the coming weeks.